Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Bayer

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Bayer Presents New Subgroup Analysis of Prespecified Pooled Analysis of Phase III Studies for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without SGLT2i Use at Baseline

November 08, 2021

From Bayer

Via Business Wire

Bayer Consumer Health Media Team Named AdExchanger Winner for Best In-House Media Operations

November 03, 2021

From Bayer

Via Business Wire

Bayer and CHS Collaborate to Bring Carbon Program Access to More Farmers

November 02, 2021

From Bayer

Via Business Wire

Bayer to present new analyses adding to the depth of knowledge on the cardiovascular and renal outcomes of KERENDIA® (finerenone)

October 27, 2021

From Bayer

Via Business Wire

During Breast Cancer Awareness Month, Bayer Shines a Light on the Impact of Breast Density on Breast Cancer Risk

October 25, 2021

From Bayer

Via Business Wire

Bayer fuels leading market positions in Crop Science through delivery of unmatched innovation

October 19, 2021

From Bayer

Via Business Wire

Bayer Appoints New General Managers for Nutritionals and Digestive Health Businesses

October 05, 2021

From Bayer

Via Business Wire

Updated Vitrakvi® (larotrectinib) Sub-Analysis at ATA 2021 Supports Efficacy and Safety in Adult and Pediatric TRK Fusion Thyroid Cancer Patients

October 04, 2021

From Bayer

Via Business Wire

Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene

October 01, 2021

From Bayer

Via Business Wire

Midol® by Bayer Receives Honorable Mention in Fast Company’s 2021 Innovation by Design Awards

September 28, 2021

From Bayer

Via Business Wire

Bayer Hires Nicole Hayes as Director of U.S. External Communications

September 28, 2021

From Bayer

Via Business Wire

On the 15th Anniversary of World Contraception Day Bayer Releases Survey Results that Highlight the Role of Contraceptives in Women’s Lives

September 27, 2021

From Bayer

Via Business Wire

Bayer Extends Clinical Development Program for KERENDIA® (finerenone) With Phase III Study to Investigate Use in Patients With Nondiabetic Chronic Kidney Disease

September 20, 2021

From Bayer

Via Business Wire

Latest Analyses of Vitrakvi® (larotrectinib) Support Consistently Meaningful Clinical Profile for Both Adult and Pediatric Patients with TRK Fusion Cancer

September 16, 2021

From Bayer

Via Business Wire

NUBEQA® (darolutamide) Impact on Local Symptoms Evaluated in Men with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

September 14, 2021

From Bayer

Via Business Wire

Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures

September 14, 2021

From Bayer

Via Business Wire

Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards

September 10, 2021

From Bayer

Via Business Wire

Bayer to Highlight Expanded Research from Growing Oncology Portfolio at ESMO Congress 2021

September 09, 2021

From Bayer

Via Business Wire

Bayer and Luke Bryan Team Up Again for “Here’s to the Farmer” Campaign

September 08, 2021

From Bayer

Via Business Wire

Bayer Starts Phase III Clinical Development Program OASIS With Investigational Product, Elinzanetant

August 31, 2021

From Bayer

Via Business Wire

Bayer Announces KERENDIA® (finerenone) Reduces the Risk of Cardiovascular Outcomes in New Phase III FIGARO-DKD Study in Adults With Chronic Kidney Disease (Stages 1-4) Associated With Type 2 Diabetes

August 28, 2021

From Bayer

Via Business Wire

FDA Label Updates Reflect Bayer’s Commitment to Women’s Healthcare

August 25, 2021

From Bayer

Via Business Wire

Bayer Announces Filing of Petition to U.S. Supreme Court for Review of Hardeman Decision

August 16, 2021

From Bayer

Via Business Wire

Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics

August 05, 2021

From Bayer

Via Business Wire

Bayer Provides Update on Path to Closure of Roundup™ Litigation

July 29, 2021

From Bayer

Via Business Wire

Denise Vitola Joins Bayer Communications Team

July 26, 2021

From Bayer

Via Business Wire

Bayer Once Again Earns Top Marks in 2021 Disability Equality Index

July 15, 2021

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

July 10, 2021

From Bayer

Via Business Wire

Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

July 09, 2021

From Bayer

Via Business Wire

Bayer Submits Regulatory Applications for Oncology Treatment Investigational Combination of Aliqopa® (copanlisib) and rituximab in the U.S. and EU

June 21, 2021

From Bayer

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.